Polyplus Builds on Research and Commercial mRNA Support Portfolio with in vivo-jetRNA®+ Transfection Reagent

The new in vivo-jetRNA®+ transfection reagent an efficient, stable, and safe delivery system leading to 100% mR...

September 8, 2022 | Thursday | News
Singapore sets up world's first integrated pre-clinical & clinical ageing research institute

The National University Health System (NUHS) has established the NUHS Centre for Healthy Longevity &...

September 7, 2022 | Wednesday | News
Australian startup OccuRx secures $16 M to progress therapies for inflammation, fibrosis

Australian biotech startup OccuRx has announcesd a $16 million cash injection to progress into clinical phase studies fo...

September 7, 2022 | Wednesday | News
Global pandemic therapeutics centre to open in Australia

The establishment of the Cumming Global Centre for Pandemic Therapeutics has been announced by the University of Melbour...

September 5, 2022 | Monday | News
India develops novel virus-like particle to combat COVID-19 & variants

A team of researchers at the Indian Institute of Science (IISc) have developed and tested a novel virus-like particle (V...

September 2, 2022 | Friday | News
China leads research of world's first spatiotemporal map of brain regeneration

A multi-institute research team led by China-based BGI Group has used BGI Stereo-seq technology to construct the world f...

September 2, 2022 | Friday | News
NZ leads world in trial of futuristic therapy

A treatment that works at the gene level to solve the root cause of a genetic disease will soon be tested at the Unive...

September 1, 2022 | Thursday | News
Hong Kong identifies innovative strategy for treatment of Alzheimer's disease

An international research team, led by Prof. Nancy IP, The Morningside Professor of Life Science at the Hong Kong Univer...

August 30, 2022 | Tuesday | News
National Genome Project in Indonesia picks MGI as technology provider

MGI Tech, based in China, has announced that the National Genome Project in Indonesia has selected MGI technol...

August 25, 2022 | Thursday | News
New Zealand calls for improvement in diagnosis of gestational diabetes

A Liggins Institute study of over 4,000 pregnant New Zealand women suggests the country can improve babies' health and r...

August 23, 2022 | Tuesday | News
Australia invests $30 M to support vital brain and mental health research

Monash University has received a $30 million philanthropic gift that will fund vital mental health research and preventa...

August 19, 2022 | Friday | News
Frontier Biotechnologies proposes treatments for acute and prolonged COVID

China-headquartered global biopharmaceutical company Frontier Biotechnologies announced positive results from the Phase ...

August 15, 2022 | Monday | News
Australia investigates how to stop painful chemo for kids

Stopping children undergoing chemotherapy from feeling pain and other debilitating side-effects is the focus of research...

August 12, 2022 | Friday | News
"Unique demands of CGT biomanufacturing necessitate an early-stage collaboration between suppliers and biomanufacturers"

A surge in pharmaceutical R&D has led to an increase in the number of Cell & Gene Therapy (CGT) candidates being...

August 11, 2022 | Thursday | Opinion
India to pioneer next-generation snakebite therapy

Bharat Serums and Vaccines (BSV), a leading biopharmaceutical company in India, has announced a meaningful collaboration...

August 9, 2022 | Tuesday | News
Korea develops new therapeutic drug for Alzheimer’s disease

Although Aduhelm, a monoclonal antibody targeting amyloid beta (Aβ), recently became the first US FDA app...

August 9, 2022 | Tuesday | News
Griffith University launches two cancer research centres with $4.6 M funding

Griffith University has launched two cancer research centres backed by $4.6 million in funding from the Australian Cance...

August 9, 2022 | Tuesday | News
New Zealand takes significant step on path to developing Alzheimer’s therapy

A brain protein with high potential to delay or reverse the onset of Alzheimer’s disease has been exploited by New...

August 5, 2022 | Friday | News